ClassID:

96390

C07H15/207 - CPC Classification

Classification description:

Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals; Carbocyclic rings Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins

Recent Application in this class:
#1
20260022140
2026-01-22

3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL

#2
20250340675
2025-11-06

NEW HYALURONIC ACID DERIVATIVES AS INNOVATIVE FILLERS

#3
20250332271
2025-10-30

PROGRAMMABLE SELECTIVE ACYLATION OF POLYOLS

#4
20250276993
2025-09-04

PSEUDO-DISACCHARIDE COMPOUNDS

#5
20250092075
2025-03-20

Glycosylation method involving trivalent iodine reagent

#6
20250084118
2025-03-13

NOVEL DEALKOXYPHENYLATION REACTION

#7
20240417419
2024-12-19

C-TERMINAL HSP90 INHIBITORS

#8
20240239830
2024-07-18

METHODS OF PREPARING CARBANUCLEOSIDES USING AMIDES

#9
20240140976
2024-05-02

PROCESS FOR PREPARING AN E-SELECTIN INHIBITOR INTERMEDIATE

#10
20240065261
2024-02-29

PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME

#11
20240043465
2024-02-08

CO-CRYSTAL FORMS OF A NOVOBIOCIN ANALOG AND PROLINE

#12
20240018174
2024-01-18

QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION

#13
20230406877
2023-12-21

COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF

#14
20230399353
2023-12-14

Amino acid derivative of glucosamine stimulating extracellular matrix synthesis and pharmaceutical composition comprising the same

#15
20230365609
2023-11-16

HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS

#16
20230302030
2023-09-28

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase

#17
20230279040
2023-09-07

PROCESS FOR PRODUCTION OF ASCARYLOSE AND RELATED COMPOUNDS

#18
20230265118
2023-08-24

SALT OF CURCUMIN MONOGLUCURONIDE

#19
20230263201
2023-08-24

GLYCOSIDE BLENDS

#20
20230256357
2023-08-17

DEVICE FOR SOLID/LIQUID EXTRACTION BY RADIAL ULTRASONIC IRRADIATION, AND ASSOCIATED EXTRACTION METHOD

#21
20230183284
2023-06-15

3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL

#22
20230138729
2023-05-04

Coumarin Derivatives of Sugar Analogs and Uses Thereof

#23
20230102047
2023-03-30

C-terminal HSP90 inhibitors

#24
20230097694
2023-03-30

E-selectin antagonist compounds, compositions, and methods of use

#25
20230079833
2023-03-16

GALACTOSE-LINKED MULTIMERIC GLYCOMIMETIC INHIBITORS OF E-SELECTINS, GALECTIN-3, AND/OR CXCR4 CHEMOKINE RECEPTORS

#26
20220298197
2022-09-22

Compounds

#27
20220289784
2022-09-15

PROCESS FOR PREPARING AN E-SELECTIN INHIBITOR INTERMEDIATE

#28
20220289783
2022-09-15

Galactoside inhibitor of galectins

#29
20220220144
2022-07-14

MULTIMERIC PAN-SELECTIN ANTAGONISTS

#30
20220185838
2022-06-16

CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN

#31
20220089630
2022-03-24

Electrocatalytic synthesis of dihydrochalcones

#32
20220041633
2022-02-10

Quinone methide analog signal amplification

#33
20210388017
2021-12-16

Compounds comprising cleavable linker and uses thereof

#34
20210386098
2021-12-16

DIHYDROCHALCONES FROM BALANOPHORA HARLANDII

#35
20210347803
2021-11-11

Amino acid derivative of glucosamine stimulating extracellular matrix synthesis and pharmaceutical composition comprising the same

#36
20210323990
2021-10-21

Highly potent multimeric e-selectin antagonists

#37
20210188891
2021-06-24

C-terminal Hsp90 inhibitors

#38
20210069222
2021-03-11

TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS

#39
20210061839
2021-03-04

Glucopyranosyl derivative and use thereof

#40
20210061838
2021-03-04

Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein

#41
20210040373
2021-02-11

Aryl-substituted saccharides or glycosides and use thereof in a drilling fluid composition

#42
20210017215
2021-01-21

E-selectin antagonist compounds, compositions, and methods of use

#43
20200407391
2020-12-31

Galactoside inhibitor of galectins

#44
20200399301
2020-12-24

Heterobifunctional inhibitors of E-selectin and galectin-3

#45
20200347088
2020-11-05

Co-crystal forms of a novobiocin analog and proline

#46
20200283465
2020-09-10

C-terminal Hsp90 inhibitors

#47
20200246365
2020-08-06

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE

#48
20200190130
2020-06-18

Sialidase inhibitors and preparation thereof

#49
20200157134
2020-05-21

E-selectin antagonist compounds, compositions, and methods of use

#50
20190359643
2019-11-28

Galactoside inhibitor of galectins

#51
20190300559
2019-10-03

Calicheamicin-antibody-drug conjugates and methods of use

#52
20190241599
2019-08-08

Co-crystal forms of a novobiocin analog and proline

#53
20190233458
2019-08-01

Highly potent multimeric e-selectin antagonists

#54
20190211045
2019-07-11

COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS

#55
20190160085
2019-05-30

Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes

#56
20190127405
2019-05-02

Quinone methide analog signal amplification

#57
20190023730
2019-01-24

C-terminal HSP90 inhibitors

#58
20180327438
2018-11-15

Carbohydrate ligands that bind to IGM antibodies against myelin-associated glycoprotein

#59
20180251486
2018-09-06

Lincomycin biosynthetic intermediates, method for preparation, and use thereof

#60
20180208620
2018-07-26

Tunicamycin related compounds with anti-bacterial activity

#61
20180066006
2018-03-08

E-selectin antagonist compounds, compositions, and methods of use

#62
20170369519
2017-12-28

METHODS FOR THE STEREOSELECTIVE PREPARATION OF APIOSE DERIVATIVES FROM ALLYLIC ALCOHOL COMPOUNDS AND ALLENE COMPOUNDS USING CATALYTIC ASYMMETRIC SYNTHESIS

#63
20170355725
2017-12-14

CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

#64
20170349619
2017-12-07

Galactoside inhibitor of galectins

#65
20170342100
2017-11-30

PROCESSES FOR THE PREPARATION OF ERTUGLIFLOZIN

#66
20170305951
2017-10-26

Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors

#67
20170298083
2017-10-19

NEW IMMUNOSTIMULATORY COMPOUNDS

#68
20170296566
2017-10-19

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS

#69
20170247401
2017-08-31

Compounds and methods for treating bacterial infections

#70
20170152280
2017-06-01

Scaphopetalone analogs and their uses

#71
20170107243
2017-04-20

Calicheamicin-antibody-drug conjugates and methods of use

#72
20170071969
2017-03-16

Treatment of metabolic disorders in equine animals

#73
20170051000
2017-02-23

C-terminal Hsp90 inhibitors

#74
20170022239
2017-01-26

Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein

#75
20160362388
2016-12-15

CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION

#76
20160289257
2016-10-06

GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV

#77
20160194667
2016-07-07

Method for producing myo-inositol and myo-inositol derivative

#78
20160145290
2016-05-26

E-selectin antagonist compounds, compositions, and methods of use

#79
20150337001
2015-11-26

extracts, fractions or compounds isolated therefrom for the treatment or prevention of hyperuricemia or gout

#80
20150284419
2015-10-08

METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF

#81
20150203523
2015-07-23

Synthesis of diverse glycosylphosphatidylinositol glycans from and their application as vaccines and diagnostics

#82
20150197538
2015-07-16

Compounds and methods for treating bacterial infections

#83
20150175644
2015-06-25

MANNOSE DERIVATIVES AS ANTAGONISTS OF BACTERIAL ADHESION

#84
20150126465
2015-05-07

PROCESS FOR PRODUCING DERIVATIVES OF PYROSTEGIA VENUSTA, DERIVATIVES OF PYROSTEGIA VENUSTA, PHARMACEUTICAL COMPOSITIONS AND ITS USES

#85
20150110808
2015-04-23

E-selectin antagonist compounds, compositions, and methods of use

#86
20150038689
2015-02-05

Reagent controlled stereoselective glycosylation

#87
20150031867
2015-01-29

Water-soluble fluorescence compound and method for preparing the same

#88
20150025030
2015-01-22

Hydroxysafflor yellow A sodium and preparation as well as application thereof

#89
20140370549
2014-12-18

Method for producing scyllo-inositol

#90
20140303359
2014-10-09

Stereoselective glycosylation reactions

#91
20140303096
2014-10-09

TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS

#92
20140296497
2014-10-02

Method for producing myo-inositol and myo-inositol derivative

#93
20140274931
2014-09-18

Compound contained in manuka honey and use of same

#94
20140274930
2014-09-18

Mannose derivatives for treating bacterial infections

#95
20140271474
2014-09-18

INHIBITOR PROBES FOR IMAGING SODIUM-GLUCOSE COTRANSPORTERS IN HEALTH AND DISEASE

#96
20140243517
2014-08-28

METHODS OF PRODUCING C-ARYL GLUCOSIDE SGLT2 INHIBITORS

#97
20140200190
2014-07-17

NOVEL GALACTOSIDE INHIBITORS OF GALECTINS

#98
20140170127
2014-06-19

Inositol pyrophosphates, and methods of use thereof

#99
20140088028
2014-03-27

Selective glycosidase inhibitors and uses thereof

#100
20140073594
2014-03-13

GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV

#101
20130303467
2013-11-14

Crystal structures of SGLT2 inhibitors and processes for preparing same

#102
20130288992
2013-10-31

Glycoside compound

#103
20130274210
2013-10-17

DENDRIMERS WITH A SACCHARIDE ENDING FOR ANTI-INFLAMMATORY PURPOSES

#104
20130267474
2013-10-10

NOVEL PHYTOCHEMICALS FROM EXTRACTS OF MAPLE SYRUPS AND MAPLE TREES AND USES THEREOF

#105
20130157968
2013-06-20

Cosmetic composition

#106
20130059820
2013-03-07

INOSITOL PYROPHOSPHATES, AND METHODS OF USE THEREOF

#107
20120309701
2012-12-06

Compounds and methods for treating bacterial infections

#108
20120270824
2012-10-25

MANNOSE DERIVATIVES AS ANTAGONISTS OF BACTERIAL ADHESION

#109
20120264924
2012-10-18

Glycorandomization and production of novel novobiocin analogs

#110
20120165277
2012-06-28

Galactoside inhibitors of galectins

#111
20120121511
2012-05-17

INFECTION DETECTION METHODS AND SYSTEMS AND RELATED COMPOUNDS AND COMPOSITIONS

#112
20120003260
2012-01-05

Solid-Phase and Solution-Phase Synthesis of Glycosylphosphatidylinositol Glycans

#113
20110281825
2011-11-17

Inositol pyrophosphates, and methods of use thereof

#114
20110257380
2011-10-20

GLYCOMIMETIC REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES

#115
20110251148
2011-10-13

GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV

#116
20110245196
2011-10-06

Sulfated oligosaccharide derivatives

#117
20110224162
2011-09-15

Synthetic analogues of phosphatidyl--inositol mannosides with an inhibitory activity of the inflammatory response

#118
20110201795
2011-08-18

Methods of Producing C-Aryl Glucoside SGLT2 Inhibitors

#119
20110172176
2011-07-14

Crystal structures of SGLT2 inhibitors and processes for preparing same

#120
20110124850
2011-05-26

Glycorandomization and production of novel erythromycin analogs

#121
20110097753
2011-04-28

Chemiluminescent methods and reagents for analyte detection

#122
20100279965
2010-11-04

Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors

#123
20100256094
2010-10-07

Inositol pyrophosphates, and methods of use thereof

#124
20080268504
2008-10-30

Glycorandomization and Production of Novel Vancomycin Analogs

#125
20080249037
2008-10-09

Synthetic molecules having immune activity

#126
20080161546
2008-07-03

Glycomimetic replacements for hexoses and N-acetyl hexosamines

#127
20080004336
2008-01-03

Crystal structures of SGLT2 inhibitors and processes for preparing same

#128
20070238866
2007-10-11

Methods of producing C-aryl glucoside SGLT2 inhibitors

#129
20070207986
2007-09-06

Inositol pyrophosphates, and methods of use thereof

#130
20060116358
2006-06-01

Inositol pyrophosphates, and methods of use thereof

#131
20060089330
2006-04-27

Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans

#132
20050266523
2005-12-01

GLYCORANDOMIZATION AND THE PRODUCTION OF NOVEL ERYTHRONOLIDE AND COUMARIN ANALOGS

#133
20050215491
2005-09-29

Compounds and their uses

#134
20050143290
2005-06-30

Substituted inositols and their use